Remnant cholesterol as a lipid-lowering target may have a long way to go

Eur Heart J. 2023 Sep 21;44(36):3481-3482. doi: 10.1093/eurheartj/ehad256.

Authors

Ye-Xuan Cao^{1

2}, Ke-Fei Dou¹, Jian-Jun Li¹

Affiliations

¹ Cardio-Metabolic Center, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, BeiLiShi Road 167, Beijing 100037, China.
² Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

PMID: 37322602
DOI: 10.1093/eurheartj/ehad256

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cholesterol*
Humans
Triglycerides

Substances

Cholesterol
Triglycerides